Terumo Co. (OTCMKTS:TRUMY) Sees Large Increase in Short Interest

Terumo Co. (OTCMKTS:TRUMY) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 3,800 shares, an increase of 46.2% from the March 31st total of 2,600 shares. Based on an average daily trading volume, of 137,800 shares, the short-interest ratio is currently 0.0 days.

Terumo Stock Down 0.1 %

OTCMKTS:TRUMY traded down $0.02 during trading hours on Friday, hitting $16.60. 78,817 shares of the company traded hands, compared to its average volume of 55,827. Terumo has a one year low of $12.56 and a one year high of $20.60. The company has a quick ratio of 1.13, a current ratio of 1.90 and a debt-to-equity ratio of 0.06. The company has a market cap of $24.75 billion, a PE ratio of 34.99 and a beta of 0.65. The firm’s 50-day simple moving average is $21.13 and its 200-day simple moving average is $17.64.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Wednesday, February 7th. The company reported $0.14 earnings per share for the quarter, hitting the consensus estimate of $0.14. The business had revenue of $1.62 billion for the quarter. Terumo had a net margin of 11.14% and a return on equity of 8.26%. Equities analysts predict that Terumo will post 0.57 earnings per share for the current year.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.